These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

720 related items for PubMed ID: 15878904

  • 1. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis.
    Nell VP, Machold KP, Stamm TA, Eberl G, Heinzl H, Uffmann M, Smolen JS, Steiner G.
    Ann Rheum Dis; 2005 Dec; 64(12):1731-6. PubMed ID: 15878904
    [Abstract] [Full Text] [Related]

  • 2. Autoantibody profiling in patients with very early rheumatoid arthritis: a follow-up study.
    Nell-Duxneuner V, Machold K, Stamm T, Eberl G, Heinzl H, Hoefler E, Smolen JS, Steiner G.
    Ann Rheum Dis; 2010 Jan; 69(1):169-74. PubMed ID: 19153104
    [Abstract] [Full Text] [Related]

  • 3. Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis.
    Barouta G, Katsiari CG, Alexiou I, Liaskos C, Varna A, Bogdanos DP, Germenis AE, Sakkas LI.
    Clin Rheumatol; 2017 Apr; 36(4):885-894. PubMed ID: 27943044
    [Abstract] [Full Text] [Related]

  • 4. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
    Berglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G, Rantapää-Dahlqvist S.
    Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T, Shimada K, Ozawa N, Hayakawa H, Hagiwara F, Nakayama H, Sugii S, Ozawa Y, Tohma S.
    J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
    [Abstract] [Full Text] [Related]

  • 6. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.
    Agrawal S, Misra R, Aggarwal A.
    Clin Rheumatol; 2007 Feb; 26(2):201-4. PubMed ID: 16572283
    [Abstract] [Full Text] [Related]

  • 7. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, Toes RE, van der Helm-van Mil AH.
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [Abstract] [Full Text] [Related]

  • 8. Immunodiagnostic significance of anti-RA33 autoantibodies in Saudi patients with rheumatoid arthritis.
    Al-Mughales JA.
    J Immunol Res; 2015 Aug; 2015():604305. PubMed ID: 25883991
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.
    Chang PY, Yang CT, Cheng CH, Yu KH.
    Int J Rheum Dis; 2016 Sep; 19(9):880-6. PubMed ID: 25940989
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Diagnostic utility of the Elecsys anti-CCP assay in patients with rheumatoid arthritis.
    Ye H, Chen F, Yan S, Zhang Y, Fang Z, Su X, Cai W, Zhang Z.
    Mod Rheumatol; 2014 Jul; 24(4):580-4. PubMed ID: 24252038
    [Abstract] [Full Text] [Related]

  • 12. Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Mediwake R, Isenberg DA, Schellekens GA, van Venrooij WJ.
    Ann Rheum Dis; 2001 Jan; 60(1):67-8. PubMed ID: 11114286
    [Abstract] [Full Text] [Related]

  • 13. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
    Us D, Gülmez D, Hasçelik G.
    Mikrobiyol Bul; 2003 Jan; 37(2-3):163-70. PubMed ID: 14593899
    [Abstract] [Full Text] [Related]

  • 14. [A comparative evaluation of the diagnostic value of anti-cyclic citrullinated peptide and rheumatoid factor in rheumatoid arthritis].
    Cho SY, Kang SY, Lee HJ, Lee WI.
    Korean J Lab Med; 2008 Feb; 28(1):39-45. PubMed ID: 18309254
    [Abstract] [Full Text] [Related]

  • 15. [Anti-cyclic citrullinated peptide antibodies and rheumatoid arthritis].
    Hayashi N, Kumagai S.
    Rinsho Byori; 2010 May; 58(5):466-79. PubMed ID: 20560456
    [Abstract] [Full Text] [Related]

  • 16. The significance of rheumatoid factor and anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus.
    Popescu C, Zofotă S, Bojincă V, Ionescu R.
    Rom J Intern Med; 2013 May; 51(3-4):179-87. PubMed ID: 24620631
    [Abstract] [Full Text] [Related]

  • 17. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
    Aridoğan BC, Kaya S, Savaş S, Cetin ES, Akkuş S, Demirci M.
    Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
    [Abstract] [Full Text] [Related]

  • 18. Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.
    Mathsson L, Mullazehi M, Wick MC, Sjöberg O, van Vollenhoven R, Klareskog L, Rönnelid J.
    Arthritis Rheum; 2008 Jan; 58(1):36-45. PubMed ID: 18163519
    [Abstract] [Full Text] [Related]

  • 19. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
    Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ.
    Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis.
    Kuru O, Bilgici A, Birinci A, Ulusoy H, Durupinar B.
    Bratisl Lek Listy; 2009 Jan; 110(10):650-4. PubMed ID: 20017459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.